• Thyroxine Binding Globulin
  • Hepatitis A Virus (HAV) Antibody Total
  • Tuberculosis Cell Mediated Immunity Antigen Response (T-SPOT®. TB) Test
  • Cytomegalovirus (CMV) Antibody, IgG, IgM
  • Hereditary Erythrocytosis Gene Mutation Panel, NGS
  • Mycoplasma hominis, Molecular
  • Dopamine beta-hydroxylase (DBH) Genetic Variations
  • Kappa and Lambda Free Light Chains, Quantitative, Serum
  • Culture, Acid-Fast Bacilli, Blood
  • Benign neoplasm, ovary
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Auria® Biological Breast Cancer Screening Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Auria® Biological Breast Cancer Screening Test
Medical Test

Methodology
Access to Auria® Biological Breast Cancer Screening Test is restricted.
Loading...